Literature DB >> 15781254

Downregulation of IL-12 and a novel negative feedback system mediated by CD25+CD4+ T cells.

Kojiro Sato1, Shoko Tateishi, Kanae Kubo, Toshihide Mimura, Kazuhiko Yamamoto, Hiroko Kanda.   

Abstract

CD25(+)CD4(+) regulatory T cells suppress immune responses and are believed to play roles in preventing autoimmune diseases. However, the mechanism(s) underlying the suppression and the regulation of their homeostasis remain to be elucidated. Here we show that these regulatory T cells downregulated CD25(-)CD4(+) T-cell-mediated production of IL-12 from antigen-presenting cells, which can act as a growth factor for CD25(-)CD4(+) T cells. We further found that CD25(+)CD4(+) T cells, despite their well-documented "anergic" nature, proliferate significantly in vitro only when CD25(-)CD4(+) T cells are present. Notably, this proliferation was strongly dependent on IL-2 and relatively independent of IL-12. Thus, CD25(+)CD4(+) T cells suppress CD25(-)CD4(+) T-cell responses, at least in part, by inhibiting IL-12 production while they themselves can undergo proliferation with the mediation of CD25(-)CD4(+) T cells in vitro. These results offer a novel negative feedback system involving a tripartite interaction among CD25(+)CD4(+) and CD25(-)CD4(+) T cells, and APCs that may contribute to the termination of immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781254     DOI: 10.1016/j.bbrc.2005.02.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs.

Authors:  Erik Berk; Ravikumar Muthuswamy; Pawel Kalinski
Journal:  Vaccine       Date:  2012-05-01       Impact factor: 3.641

Review 2.  The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance.

Authors:  Nona Janikashvili; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Clin Dev Immunol       Date:  2011-11-03

3.  The Immunomodulatory Effect of You-Gui-Wan on Dermatogoides-pteronyssinus-Induced Asthma.

Authors:  Li-Jen Lin; Chin-Che Lin; Shulhn-Der Wang; Yun-Peng Chao; Shung-Te Kao
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-20       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.